| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |